What’s new: Pfizer Inc. CEO Albert Bourla shot down reports that the pharmaceutical giant is working with a company in China to make generic versions of its breakthrough Covid drug Paxlovid for the domestic market.
However, domestic production of branded Paxlovid for the local market is expected to start in the first half of the year, Bourla said Monday at the JPMorgan Healthcare Conference in San Francisco.
